TROOPS ARREST SUSPECTED KIDNAPPER, RECOVER AK-47 RIFLE ALONG BENIN–SAPELE ROAD. (PHOTO). #PRESS RELEASE

Image
 TROOPS ARREST SUSPECTED KIDNAPPER, RECOVER AK-47 RIFLE ALONG BENIN–SAPELE ROAD Troops of 4 Brigade Nigerian Army, Operation WABAIZIGAN, have arrested a suspected kidnapper and recovered an AK-47 rifle and ammunition during a targeted operation along the Benin–Sapele Road in Ikpoba-Okha LGA of Edo State. The suspect, identified as Olamide Oyeniyi, was arrested on 12 September 2026 at Obaretin Community by troops conducting operations to disrupt criminal activities and safeguard major transportation routes within the area. Items recovered from the suspect include one AK-47 rifle, one magazine and eight rounds of 7.62mm Special ammunition. Other items recovered are one Tecno mobile phone, two bags, one torchlight, one music box and assorted charms. The suspect and recovered items are currently in troops’ custody for further investigation, while efforts are ongoing to establish his links to other criminal elements and determine his possible involvement in kidnapping and related activi...

GSK CEO TO RESIGN BY THE END OF THE YEAR. (PHOTO).


 GSK CEO to resign by the end of the year

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down on Dec. 31 after more than eight years at the helm of the London-based drugmaker.

Walmsley, 56, will be succeeded by Luke Miels, currently GSK’s chief commercial officer, the company announced Monday. During her tenure, Walmsley oversaw several strategic initiatives, including the spinoff of the consumer health business Haleon, but the company’s overall performance has underwhelmed investors. GSK shares rose 3.3% to 1,534.50 pence in early trading, making it the top gainer on the London Stock Exchange.

Despite these gains, GSK’s stock has fallen 11% since Walmsley took over on April 1, 2017. Analysts say the company has delivered on financial guidance but continues to experience slow growth. Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown, noted that while GSK has achieved progress, “the share price performance has been lackluster” and growth rates remain in the single digits.

Comments

Popular posts from this blog

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.